United States, July 8 -- Evonik, one of the world's leading specialty chemicals companies, is making a significant investment to strengthen manufacturing capabilities at its Tippecanoe Labs site in Lafayette, Indiana. The site is home to one of the world's largest facilities for the production of active pharmaceutical ingredients (APIs), the industry's biggest high-potency API operation, and a major employer in the Greater Lafayette region.Over the next five years, Evonik will invest US$100 million to modernize key equipment - including large reactors and other critical systems - enhancing reliability, enabling greater automation, and improving ergonomics and efficiency. This upgrade positions Evonik to meet the rapidly growing demand for U...